The study on renal carcinoma cells figure out an outstanding fact, that BTL expression is severely down-regulated in the renal cortical tumors [61], therefore the BTL assessment with specific BTL antibodies could serve as a novel biomarker of human kidney cancers [60]. The gene discussed is CHIC2; the disease is renal carcinoma.